COMPUTATIONAL PIPELINE FOR THE IDENTIFICATION OF HLA SOMATIC MUTATIONS: CAN SNV/INDELS EXPLAIN IMMUNOTHERAPY FAILURE IN NON-MUSCLE INVASIVE BLADDER CANCER?